vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $66.9M, roughly 1.1× Energy Recovery, Inc.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -121.9%, a 162.1% gap on every dollar of revenue. On growth, Energy Recovery, Inc. posted the faster year-over-year revenue change (-0.3% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $6.4M). Over the past eight quarters, Energy Recovery, Inc.'s revenue compounded faster (8.1% CAGR vs -0.0%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

ERII vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.1× larger
HCAT
$74.7M
$66.9M
ERII
Growing faster (revenue YoY)
ERII
ERII
+5.9% gap
ERII
-0.3%
-6.2%
HCAT
Higher net margin
ERII
ERII
162.1% more per $
ERII
40.2%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$3.2M more FCF
HCAT
$9.6M
$6.4M
ERII
Faster 2-yr revenue CAGR
ERII
ERII
Annualised
ERII
8.1%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
HCAT
HCAT
Revenue
$66.9M
$74.7M
Net Profit
$26.9M
$-91.0M
Gross Margin
67.2%
Operating Margin
46.8%
-115.3%
Net Margin
40.2%
-121.9%
Revenue YoY
-0.3%
-6.2%
Net Profit YoY
14.7%
-340.3%
EPS (diluted)
$0.49
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
HCAT
HCAT
Q4 25
$66.9M
$74.7M
Q3 25
$32.0M
$76.3M
Q2 25
$28.1M
$80.7M
Q1 25
$79.4M
Q4 24
$67.1M
$79.6M
Q3 24
$38.6M
$76.4M
Q2 24
$27.2M
$75.9M
Q1 24
$12.1M
$74.7M
Net Profit
ERII
ERII
HCAT
HCAT
Q4 25
$26.9M
$-91.0M
Q3 25
$3.9M
$-22.2M
Q2 25
$2.1M
$-41.0M
Q1 25
$-23.7M
Q4 24
$23.5M
$-20.7M
Q3 24
$8.5M
$-14.7M
Q2 24
$-642.0K
$-13.5M
Q1 24
$-8.3M
$-20.6M
Gross Margin
ERII
ERII
HCAT
HCAT
Q4 25
67.2%
Q3 25
64.2%
52.6%
Q2 25
64.0%
Q1 25
Q4 24
70.2%
Q3 24
65.1%
47.5%
Q2 24
64.6%
Q1 24
59.0%
Operating Margin
ERII
ERII
HCAT
HCAT
Q4 25
46.8%
-115.3%
Q3 25
11.4%
-22.9%
Q2 25
5.3%
-46.0%
Q1 25
-25.4%
Q4 24
38.2%
-22.0%
Q3 24
18.3%
-17.9%
Q2 24
-7.4%
-20.8%
Q1 24
-90.4%
-30.5%
Net Margin
ERII
ERII
HCAT
HCAT
Q4 25
40.2%
-121.9%
Q3 25
12.1%
-29.1%
Q2 25
7.3%
-50.8%
Q1 25
-29.9%
Q4 24
35.0%
-26.0%
Q3 24
22.0%
-19.3%
Q2 24
-2.4%
-17.8%
Q1 24
-68.3%
-27.6%
EPS (diluted)
ERII
ERII
HCAT
HCAT
Q4 25
$0.49
$-1.29
Q3 25
$0.07
$-0.32
Q2 25
$0.04
$-0.59
Q1 25
$-0.35
Q4 24
$0.40
$-0.33
Q3 24
$0.15
$-0.24
Q2 24
$-0.01
$-0.23
Q1 24
$-0.14
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$75.2M
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$206.2M
$245.8M
Total Assets
$231.5M
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
HCAT
HCAT
Q4 25
$75.2M
$95.7M
Q3 25
$70.4M
$91.5M
Q2 25
$79.5M
$97.3M
Q1 25
$342.0M
Q4 24
$78.0M
$392.0M
Q3 24
$118.6M
$387.3M
Q2 24
$101.0M
$308.3M
Q1 24
$117.4M
$327.8M
Total Debt
ERII
ERII
HCAT
HCAT
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
ERII
ERII
HCAT
HCAT
Q4 25
$206.2M
$245.8M
Q3 25
$180.8M
$331.9M
Q2 25
$185.2M
$347.5M
Q1 25
$376.8M
Q4 24
$210.0M
$365.2M
Q3 24
$233.9M
$355.0M
Q2 24
$218.5M
$357.0M
Q1 24
$216.0M
$357.2M
Total Assets
ERII
ERII
HCAT
HCAT
Q4 25
$231.5M
$502.6M
Q3 25
$209.6M
$587.1M
Q2 25
$212.3M
$616.2M
Q1 25
$891.5M
Q4 24
$242.8M
$858.9M
Q3 24
$262.7M
$813.0M
Q2 24
$249.0M
$691.7M
Q1 24
$244.3M
$695.1M
Debt / Equity
ERII
ERII
HCAT
HCAT
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
HCAT
HCAT
Operating Cash FlowLast quarter
$7.1M
$9.9M
Free Cash FlowOCF − Capex
$6.4M
$9.6M
FCF MarginFCF / Revenue
9.6%
12.9%
Capex IntensityCapex / Revenue
1.0%
0.4%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
HCAT
HCAT
Q4 25
$7.1M
$9.9M
Q3 25
$-3.1M
$-464.0K
Q2 25
$4.1M
$-9.0M
Q1 25
$280.0K
Q4 24
$9.0M
$-3.5M
Q3 24
$-3.0M
$6.2M
Q2 24
$8.1M
$1.6M
Q1 24
$6.5M
$10.3M
Free Cash Flow
ERII
ERII
HCAT
HCAT
Q4 25
$6.4M
$9.6M
Q3 25
$-3.5M
$-719.0K
Q2 25
$4.0M
$-9.2M
Q1 25
$-390.0K
Q4 24
$8.9M
$-3.9M
Q3 24
$-3.2M
$5.5M
Q2 24
$7.9M
$1.3M
Q1 24
$5.7M
$10.1M
FCF Margin
ERII
ERII
HCAT
HCAT
Q4 25
9.6%
12.9%
Q3 25
-10.9%
-0.9%
Q2 25
14.3%
-11.4%
Q1 25
-0.5%
Q4 24
13.2%
-4.9%
Q3 24
-8.2%
7.2%
Q2 24
28.9%
1.7%
Q1 24
46.9%
13.5%
Capex Intensity
ERII
ERII
HCAT
HCAT
Q4 25
1.0%
0.4%
Q3 25
1.1%
0.3%
Q2 25
0.5%
0.3%
Q1 25
0.8%
Q4 24
0.2%
0.5%
Q3 24
0.4%
0.9%
Q2 24
0.7%
0.4%
Q1 24
6.8%
0.3%
Cash Conversion
ERII
ERII
HCAT
HCAT
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
Q3 24
-0.35×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons